Skip to content

Improvisational Movement for People With Memory Loss and Their Caregivers

IMOVE: Improvisational Movement for People With Memory Loss and Their Caregivers

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03333837
Acronym
IMOVE
Enrollment
104
Registered
2017-11-07
Start date
2018-02-06
Completion date
2021-05-26
Last updated
2022-07-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimer's Disease (Incl Subtypes), Dementia, Mild Cognitive Impairment

Keywords

Improvisation, Memory loss, Caregivers, Quality of Life, Dance, Social Group, MRI, mild cognitive impairment, MCI, Social engagement

Brief summary

Dementia is a progressive decline in cognition that impairs a person's ability to perform activities of daily living. Changes in mood, gait, and balance are prominent secondary symptoms of Alzheimer's dementia that can dramatically decrease quality of life for the person with dementia and increase caregiver burden. The overall aim of this study is to determine the independent and combined effects of dance movement and social engagement on quality of life in people with early-stage dementia, and test the neural mechanisms of these effects.

Detailed description

Dementia is a progressive decline in cognition that impairs a person's ability to perform activities of daily living. Alzheimer's disease is the most common form of dementia, the most common neurodegenerative disease in older adults, and the 6th leading cause of death in the US. Neuropsychiatric symptoms (apathy, depression, anxiety) and altered gait and balance are prominent secondary symptoms of Alzheimer's disease that increase medical costs and decrease quality of life for both the person with dementia and their caregiver. In a report from the Secretariat (Executive Board, 134th Session, December 20th, 2013), the World Health Organization identified a need to integrate evidence-based palliative care services into the continuum of care for serious chronic diseases, including Alzheimer's disease. However, two recent NIH workshops identified major gaps in the evidence supporting the wider use of non-pharmacologic activities to ameliorate secondary symptoms of chronic disease. Arts-based activities were identified as particularly understudied for symptom management, given growing evidence that various arts-based activities can improve quality of life, relieve symptoms, and reduce reliance on medications. It is important that these benefits can be achieved without adding medications. Dance is an arts-based activity that can improve quality of life, decrease symptoms of depression, and improve balance in healthy older adults, those with Parkinson disease, and Alzheimer's disease. Thus, dance is a non-pharmacological intervention that simultaneously addresses two sets of prominent secondary symptoms in Alzheimer's disease: 1) gait and balance and 2) neuropsychiatric symptoms. However, the mechanisms through which dance exerts these effects are unknown. Pilot data from the investigators' laboratory suggest that participating in a group improvisational movement class twice weekly improved balance and connectivity in motor-related brain regions, as well as improving mood and connectivity in brain regions associated with social engagement. Improvisation is the ability to create new gestures and movements spontaneously. Improvisation can be a part of many different art forms. However, improvisational movement can also be practiced as a specific dance form. The objective in improvisational movement is that choreographed movement is replaced by a cue or prompt that allows the possibility for multiple responses. This unique form of dance is especially well-suited for people with dementia because it: 1) does not rely heavily on memory of repeated movements; 2) can be seamlessly adapted to include sitting, standing, or moving around the room; 3) is cognitively challenging; and 4) fosters a social, playful atmosphere. Participants seemed to benefit from both the social nature of the class and the movement. Therefore, the overall aim of this proposal is to experimentally determine the independent and combined effects of dance movement and social engagement on quality of life in people with early stage dementia, and test the neural mechanisms of these effects. To accomplish this goal, the investigators will use a 2x2 factorial design and randomize 120 community-dwelling older adults adjudicated as having early-stage dementia of the presumed Alzheimer's type to one of four 3-month interventions: 1) Dance Group, 2) Non-group Dance, 3) Social Group, or 4) No Contact Control. It is not hypothesized that dance affects the underlying disease course, and therefore no improvement is expected in cognition.

Interventions

BEHAVIORALDance Group

Active imagination refers to working with imagery and is crucial in improvisatory practice. Verbal auditory cues are used to create movement scenarios that cue or activate the motor imagination. Variability means the improvisational method does not aim to learn a specific movement pattern and habituate to it. Cues are delivered quickly, one after another. Within an average of two minutes, tasks requiring quicker decision-making are introduced. Pacing is the rate at which new movement prompts are presented. Quick changes in pace avoid defaulting to habitual responses, thereby facilitating new movement options. Participants cannot rely on copying another, memory, or anticipation to address the motor problem.

BEHAVIORALNon-Group Dance

The caregiver will be asked to stay in the area while the subject is dancing. A video camera will be affixed in an upper corner of the room to record individual dance sessions. This recording will yield data that a trained student or staff member can view and code to document movement fidelity (e.g., that the person has responded to the dance prompts and for the purpose of comparing the amount of quality of movements that occur in individual vs. group dance settings). For the first two sessions, study staff would observe the full dance session from outside the room to be sure that instruction was clear and adherence was attained, and that no safety issues arise.

BEHAVIORALSocial Group

The social group will consist of improvisational party games to foster curiosity and playfulness, use imagery, and encourage non-judgment. Games that may be used include 'Balderdash', 'Wise and Otherwise', 'Charades', 'Pictionary', and 'Tell Me A Story' cards. These games will also use the same core strategies as the dance group. Games will be varied within an hour-long session to incorporate pacing and variability into the social group, akin to the dance group. The social group will occur 2x/week for 1 hour each time and be led by the same instructors who lead the Dance Group, to control for effects of personality of the group leader.

BEHAVIORALNo Contact

The condition of not receiving an intervention can have ethical implications and reduce retention rates. Therefore, these participants will be invited to join in a weekly community improvisational dance class after they complete the study, for as many sessions as they would like.

Sponsors

National Center for Complementary and Integrative Health (NCCIH)
CollaboratorNIH
Wake Forest University Health Sciences
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Outcomes Assessor)

Masking description

All study assessments will be conducted by experienced staff certified annually on the proper conduct of study assessments and blinded to group assignment.

Intervention model description

Randomized controlled trial. Investigators will use a 2x2 factorial design to test the separate and combined effects of social engagement and dance movement on QoL in 120 community-dwelling older adults adjudicated as having mild cognitive impairment (MCI) or early-stage dementia of the presumed AD or mixed AD/vascular type. Participants will be randomized to one of four 12-week interventions: 1) Dance Group 2) Non-group Dance, 3) Social Group, or 4) No Contact Control.

Eligibility

Sex/Gender
ALL
Age
60 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

Age 60-85 years Adjudicated as having mild cognitive impairment or early-stage dementia of Alzheimer's, vascular, or mixed Alzheimer's/vascular type MRI compatible English speaking Have study partner who is around the person with dementia approximately 10 hours/week and is willing to be an active study partner. Able to attend bi-weekly intervention classes or come to study visits for no-contact control. Not enrolled in another interventional study for at least 3 months prior to beginning this study.

Exclusion criteria

Untreated depression Other causes of dementia (for example, frontotemporal, early onset, Lewy body or Parkinsonian dementia) Current cancer treatment or other major medical problems that might independently affect cognition or movement Other neurological disorders (e.g., Parkinson disease, multiple sclerosis) Taking medication that could negatively influence safety during intervention Planned extensive travel during the study period Any reason for which the study doctor or personal physician feels the intervention is contraindicated for the participant

Design outcomes

Primary

MeasureTime frameDescription
Quality of Life in Alzheimer's Disease (QOL-AD)--Participants With Dementia (PWD)BaselineSelf-reported quality of life in the person with dementia is the primary outcome and will be measured using the QOL-AD . The QOL-AD is validated for use in people with Mini Mental State Exam scores as low as 10.The QOL\_AD contains 13 items.Points are assigned to each item as follows: poor = 1, fair = 2, good = 3, excellent = 4.The total score is the sum of all 13 item (range 13- 52) higher scores represent better outcomes.
QOL-AD--PWDWeek 12Self-reported quality of life in the person with dementia is the primary outcome and will be measured using the QOL-AD . The QOL-AD is validated for use in people with Mini Mental State Exam scores as low as 10.The QOL\_AD contains 13 items.Points are assigned to each item as follows: poor = 1, fair = 2, good = 3, excellent = 4.The total score is the sum of all 13 item (range 13- 52) higher scores represent better outcomes.

Secondary

MeasureTime frameDescription
Fullerton Advanced Balance Scale (Overall Balance) PWDBaselineFullerton Advanced Balance Scale (FAB) measures balance using 10 different performance-based tests (scored 0 worst - 4 best), including; standing with feet together and eyes closed, standing on a foam pad with eyes closed, walking while turning the head from side to side rhythmically, functional standing reach, turning around to the left and right, stepping up and over a 6-inch box, standing on one leg, and a test for postural reaction. The scale goes from 0-40 with 40 being the best outcome and a cutoff of \<=25 for risk of falls.
Geriatric Depression ScaleBaselineThe person with dementia will be asked to complete a screening tool for assessing depression. This test has 15 yes/no questions with a yes receiving 1 point for a depressive answer. A total score is calculated and will be on a scale from 0-15 with 0-4 indicating no depression, 5-10 suggestive of a mild depression, and 11+ suggestive of severe depression.
Geriatric Anxiety ScaleBaselineThe Geriatric Anxiety Scale measures symptoms of anxiety in older adults. A single total score ranges from 0 (low anxiety) to 63 (high anxiety). Four cutoff scores have been provided by authors in the manuals: 0-7 (normal anxiety), 8-15 (mild-moderate anxiety), 16-25 (moderate-severe anxiety), and 26-63 (severe anxiety).
Apathy Evaluation Scale--PWDBaselineThe Apathy Evaluation Scale (AES) addresses characteristics of goal directed behavior that reflect apathy including behavioral, cognitive, and emotional indicators. A short form will be used that has been modified for use with people with dementia. This shortened version has 10 questions scored 1-4 with 4 being the positive outcome answer. The total score is calculated and on a scale of 10-40 with lower scores reflecting less apathy and thus a better outcome.
Expanded Short Physical Performance Battery (eSPPB)BaselineThe eSPPB is a brief test of global mobility function with excellent test-retest and inter-examiner reliability; is sensitive to change; is safe, and is a robust predictor of future physical disability and death. To avoid ceiling effects, investigators will use an expanded version (eSPPB) that increases the difficulty of the standing balance task by asking participants to hold postures for 30 instead of 10 seconds, adds a one-leg stand, and adds a narrow walk. The resulting score is normally distributed, continuous, and shows greater sensitivity to change. Dementia patients have lower scores on the SPPB so a favorable outcome for this outcome measure would be a significantly higher score post treatment. The eSPPB is scored as a continuous measure with a minimum score of 0 and a maximum score of 3.0 where 3 is the best possible outcome.
Postural Sway--PWDBaselineCenter of pressure displacement (area of the 95% confidence ellipse) using an AccuSway forceplate. Center of pressure displacement is one way to characterize postural sway. Increased postural sway is correlated with decreased balance in older adults and increased fall risk. Center of pressure displacement was measured using the area of the 95% confidence ellipse using an AccuSway forceplate. Higher numbers indicate greater levels of postural sway.
Gait Speed--PWDBaselineThe time one takes to walk a specified distance on level surfaces over a short distance. 4m usual gait speed was measured as part of the eSPPB.
Gait Variability--PWDBaselineStride time variability, which is calculated out of the mean and standard deviation of stride time, reflects the change in time elapsed between the first two contacts of two consecutive footfalls of the same foot over a number of gait cycles. Increased gait variability is associated with increased fall risk in older adults.
Falls Efficacy Scale - International (FES) PWDBaselineA 16-item scale to assess fear of falling where higher scores reflect a higher fear and risk of falling. Out of a total score of 100, a score of 70 or above indicates the individual has a fear of falling.
Community Structure--PWDBaselineThis is a brain imaging variable derived from fMRI images. Modularity (Q) ranges from 0 (no community structure) to 1 (perfectly modular network). One Q-value is generated for each person and group averages are shown.
Global Efficiency (eGlob)--PWDBaselineThis is a brain imaging variable derived from fMRI images.Scale ranges from 0 (no long-range information processing) to 1 (maximal distributed processing). Decreased Eglob has been associated with aging, cognitive impairment, and depression.
Local Efficiency (eLoc)--PWDBaselineScale ranges from 0 (no local connectivity) to 1 (maximal local connectivity - all connections are local) and has been observed to change with cognitive impairment and depression.
Path Length--PWDBaselineRefers to the number of edges that must be crossed to get from one node to another. Longer path length in people with AD has been associated with slower cognitive performance, beta amyloid deposition, and depression.
Neuropsychiatric Inventory Questionnaire (NPI-Q)BaselineThe NPI is a reliable and valid structured interview designed to assess neuropsychiatric symptoms in person with dementia through a structured interview with the caregiver. The NPI includes questions about 12 domains of symptoms: delusions, hallucinations, agitation/aggression, depression, anxiety, elation/ euphoria, apathy, disinhibition, irritability, aberrant motor activity, sleep, and eating. For each, symptom severity is scored on a scale of 0-4, with 4 being the worst outcome and caregiver distress is scored on a scale from 0-5, with 5 being the worst outcome. The sum of all 12 domains is calculated. Severity scores are reported here with a range from 0-36 with a higher score reflecting greater symptom severity.
NPI-QWeek 12The NPI is a reliable and valid structured interview designed to assess neuropsychiatric symptoms in person with dementia through a structured interview with the caregiver. The NPI includes questions about 12 domains of symptoms: delusions, hallucinations, agitation/aggression, depression, anxiety, elation/ euphoria, apathy, disinhibition, irritability, aberrant motor activity, sleep, and eating. For each, symptom severity is scored on a scale of 0-4, with 4 being the worst outcome and caregiver distress is scored on a scale from 0-5, with 5 being the worst outcome. The sum of all 12 domains is calculated. Severity scores are reported here with a range from 0-36 with a higher score reflecting greater symptom severity.

Other

MeasureTime frameDescription
White Matter Lesion BurdenBaseline, Week 12The volume of white matter lesions is calculated using the Lesion Segmentation Toolbox. PWD only.
Blood-based Stress Biomarkers (Covariate or Alternative Hypothesis)Baseline, Week 12Social engagement may change biomarkers of stress relevant for interpreting outcomes. These stress biomarkers include cortisol and allostatic load, a composite measure of blood-based biomarkers associated with chronically elevated stress. PWD only
Caregiver Quality of Life With the 36-item Short-Form Health (SF-36)--Covariate or Alternative HypothesisBaseline, Week 12The SF-36 consists of 36 questions assessing physical functioning, role functioning difficulties caused by physical problems, bodily pain, general health, vitality, social functioning, role functioning difficulties caused by emotional problems, and mental health. High scores are representative of a great health status and better outcomes, while low scores are representative of a poor health status.
Caregiver Burden With Zarit Caregiver Burden Scale--Covariate or Alternative HypothesisBaseline, Week 12The Zarit Caregiver Burden Scale is administered in interview form to the caregiver. It consists of 22 questions scored 0-4 with 0=Never, 1=Rarely, 2=Sometimes, 3=Quite Frequently, 4=Nearly Always. The total score range is 0-88 with 88 being the worst possible outcome. 0-20 represents little or no burden on the caregiver, 21-40 represents mild to moderate burden, 41-60 represents moderate to severe burden, and 61-88 represents severe burden.
Blood PressureBaseline, Week12PWD only
Neuroticism-Extraversion-Openness Five-Factor Inventory (NEO-FFI)BaselineA measure of five domains of personality (neuroticism, extraversion, openness, agreeableness, and conscientiousness). A higher score on any scale indicates stronger presence of that trait. PWD only
Body Mass Index (BMI)Baseline, Week 12a measure of body fat based on height and weight that applies to adult men and women--PWD only

Countries

United States

Participant flow

Recruitment details

All Persons With Dementia (PWDs) were enrolled with one caregiver each. There was never a time when one was enrolled without the other, so these two people are represented in the participant flow as a dyad.

Pre-assignment details

Participants were enrolled in dyads consisting of one person with dementia (PWD) and one caregiver (CG). Participant flow section includes numbers as dyad since both were considered enrolled. Elsewhere in the record, numbers include either participants with dementia or caregivers as indicated in baseline analysis population description and in outcome titles or descriptions.

Participants by arm

ArmCount
Dance Group
The Dance Group will participate in 1-hour group improvisational dance lessons 2x/week for 12 weeks. Improvisational dance classes are grounded in 4 principles that shape the tone of the class and result in a sense of social belonging: non-judgment, non-competitiveness, curiosity, and playfulness. The following training strategies are used to maintain: active imagination, variability, and pacing. Dance Group: Active imagination refers to working with imagery and is crucial in improvisatory practice. Verbal auditory cues are used to create movement scenarios that cue or activate the motor imagination. Variability means the improvisational method does not aim to learn a specific movement pattern and habituate to it. Cues are delivered quickly, one after another. Within an average of two minutes, tasks requiring quicker decision-making are introduced. Pacing is the rate at which new movement prompts are presented. Quick changes in pace avoid defaulting to habitual responses, thereby facilitating new movement options. Participants cannot rely on copying another, memory, or anticipation to address the motor problem.
24
Non-group Dance
The Non-group dance intervention is designed to capture the same dance movement and auditory stimuli as the group class without social interaction. Recordings of the dance instructor teaching a dance class will be played. This will ensure participants hear comparable music and receive comparable verbal auditory cues to prompt dance movements that students in the group class will hear, without interacting with other people. Improvisational dance is particularly suited for this means of delivery because the primary method of instruction is verbal auditory cueing. Participants will be asked to follow the same schedule as participants in the Dance Group arm and complete 2 one-hour dance sessions each week. Non-Group Dance: The caregiver will be asked to stay in the area while the subject is dancing. A video camera will be affixed in an upper corner of the room to record individual dance sessions. This recording will yield data that a trained student or staff member can view and code to document movement fidelity (e.g., that the person has responded to the dance prompts and for the purpose of comparing the amount of quality of movements that occur in individual vs. group dance settings). For the first two sessions, study staff would observe the full dance session from outside the room to be sure that instruction was clear and adherence was attained, and that no safety issues arise.
25
Social Group
The social group will consist of improvisational party games to foster curiosity and playfulness, use imagery, and encourage non-judgment. Games that may be used include 'Balderdash', 'Wise and Otherwise', 'Charades', 'Pictionary', and 'Tell Me A Story' cards. These games will also use the same core strategies as the dance group. Games will be varied within an hour-long session to incorporate pacing and variability into the social group, akin to the dance group. The social group will occur 2x/week for 1 hour each time and be led by the same instructors who lead the Dance Group, to control for effects of personality of the group leader. Social Group: The social group will consist of improvisational party games to foster curiosity and playfulness, use imagery, and encourage non-judgment. Games that may be used include 'Balderdash', 'Wise and Otherwise', 'Charades', 'Pictionary', and 'Tell Me A Story' cards. These games will also use the same core strategies as the dance group. Games will be varied within an hour-long session to incorporate pacing and variability into the social group, akin to the dance group. The social group will occur 2x/week for 1 hour each time and be led by the same instructors who lead the Dance Group, to control for effects of personality of the group leader.
27
No Contact
A No Contact condition captures the condition of no added social contact and no added dance movement. Participants randomized to the No Contact condition will be asked to continue their current disease management and lifestyle for 12 weeks No Contact: The condition of not receiving an intervention can have ethical implications and reduce retention rates. Therefore, these participants will be invited to join in a weekly community improvisational dance class after they complete the study, for as many sessions as they would like.
25
Never Randomized
Subject dyads who signed consent but withdrew prior to randomization.
3
Total104

Withdrawals & dropouts

PeriodReasonFG000FG001FG002FG003FG004
Overall StudyAdverse Event21110
Overall StudyCaregiver withdrew02100
Overall StudyCOVID interrupted enrollment--had to rescreen and didn't qualify00200
Overall StudyWithdrawal by Subject00113

Baseline characteristics

CharacteristicDance GroupTotalNever RandomizedNo ContactSocial GroupNon-group Dance
Age, Continuous75.33 years
STANDARD_DEVIATION 5.94
75.29 years
STANDARD_DEVIATION 6.45
69.87 years
STANDARD_DEVIATION 3.23
76.0 years
STANDARD_DEVIATION 6.43
76.75 years
STANDARD_DEVIATION 6.29
73.62 years
STANDARD_DEVIATION 7.1
Ethnicity (NIH/OMB)
Hispanic or Latino
0 Participants0 Participants0 Participants0 Participants0 Participants0 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
24 Participants103 Participants3 Participants25 Participants27 Participants24 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants1 Participants0 Participants0 Participants0 Participants1 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
1 Participants2 Participants0 Participants0 Participants1 Participants0 Participants
Race (NIH/OMB)
Black or African American
2 Participants13 Participants0 Participants2 Participants6 Participants3 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
21 Participants89 Participants3 Participants23 Participants20 Participants22 Participants
Region of Enrollment
United States
24 participants104 participants3 participants25 participants27 participants25 participants
Sex: Female, Male
Female
12 Participants50 Participants0 Participants11 Participants14 Participants13 Participants
Sex: Female, Male
Male
12 Participants54 Participants3 Participants14 Participants13 Participants12 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
EG003
affected / at risk
EG004
affected / at risk
EG005
affected / at risk
EG006
affected / at risk
EG007
affected / at risk
EG008
affected / at risk
EG009
affected / at risk
deaths
Total, all-cause mortality
0 / 240 / 240 / 250 / 250 / 270 / 270 / 250 / 251 / 30 / 3
other
Total, other adverse events
15 / 2413 / 2415 / 255 / 2511 / 278 / 2717 / 2515 / 250 / 30 / 3
serious
Total, serious adverse events
1 / 244 / 240 / 252 / 252 / 274 / 274 / 252 / 253 / 31 / 3

Outcome results

Primary

QOL-AD--PWD

Self-reported quality of life in the person with dementia is the primary outcome and will be measured using the QOL-AD . The QOL-AD is validated for use in people with Mini Mental State Exam scores as low as 10.The QOL\_AD contains 13 items.Points are assigned to each item as follows: poor = 1, fair = 2, good = 3, excellent = 4.The total score is the sum of all 13 item (range 13- 52) higher scores represent better outcomes.

Time frame: Week 12

Population: Overall number of participants analyzed corresponds to the number of participants who completed the study.

ArmMeasureValue (MEAN)Dispersion
Dance GroupQOL-AD--PWD35.23 score on a scaleStandard Deviation 6.54
Non-group DanceQOL-AD--PWD40.0 score on a scaleStandard Deviation 5.36
Social GroupQOL-AD--PWD36.68 score on a scaleStandard Deviation 4.76
No ContactQOL-AD--PWD35.96 score on a scaleStandard Deviation 8.04
Primary

Quality of Life in Alzheimer's Disease (QOL-AD)--Participants With Dementia (PWD)

Self-reported quality of life in the person with dementia is the primary outcome and will be measured using the QOL-AD . The QOL-AD is validated for use in people with Mini Mental State Exam scores as low as 10.The QOL\_AD contains 13 items.Points are assigned to each item as follows: poor = 1, fair = 2, good = 3, excellent = 4.The total score is the sum of all 13 item (range 13- 52) higher scores represent better outcomes.

Time frame: Baseline

Population: Results at baseline for this outcome represent all PWD who were randomized.

ArmMeasureValue (MEAN)Dispersion
Dance GroupQuality of Life in Alzheimer's Disease (QOL-AD)--Participants With Dementia (PWD)35.42 score on a scaleStandard Deviation 5.02
Non-group DanceQuality of Life in Alzheimer's Disease (QOL-AD)--Participants With Dementia (PWD)38.10 score on a scaleStandard Deviation 4.6
Social GroupQuality of Life in Alzheimer's Disease (QOL-AD)--Participants With Dementia (PWD)35.56 score on a scaleStandard Deviation 4.15
No ContactQuality of Life in Alzheimer's Disease (QOL-AD)--Participants With Dementia (PWD)36.12 score on a scaleStandard Deviation 5.75
Secondary

Apathy Evaluation Scale--PWD

The Apathy Evaluation Scale (AES) addresses characteristics of goal directed behavior that reflect apathy including behavioral, cognitive, and emotional indicators. A short form will be used that has been modified for use with people with dementia. This shortened version has 10 questions scored 1-4 with 4 being the positive outcome answer. The total score is calculated and on a scale of 10-40 with lower scores reflecting less apathy and thus a better outcome.

Time frame: Baseline

Population: Results at baseline for this outcome represent all PWD who were randomized.

ArmMeasureValue (MEAN)Dispersion
Dance GroupApathy Evaluation Scale--PWD21.83 score on a scaleStandard Deviation 8.49
Non-group DanceApathy Evaluation Scale--PWD18.88 score on a scaleStandard Deviation 6.23
Social GroupApathy Evaluation Scale--PWD19.74 score on a scaleStandard Deviation 7.04
No ContactApathy Evaluation Scale--PWD18.44 score on a scaleStandard Deviation 7.53
Secondary

Apathy Evaluation Scale--PWD

The Apathy Evaluation Scale (AES) addresses characteristics of goal directed behavior that reflect apathy including behavioral, cognitive, and emotional indicators. A short form will be used that has been modified for use with people with dementia. This shortened version has 10 questions scored 1-4 with 4 being the positive outcome answer. The total score is calculated and on a scale of 10-40 with lower scores reflecting less apathy and thus a better outcome.

Time frame: Week 12

Population: One participant is missing follow-up data due to a recording error during data collection.

ArmMeasureValue (MEAN)Dispersion
Dance GroupApathy Evaluation Scale--PWD19.32 score on a scaleStandard Deviation 9.89
Non-group DanceApathy Evaluation Scale--PWD19.0 score on a scaleStandard Deviation 6.61
Social GroupApathy Evaluation Scale--PWD18.68 score on a scaleStandard Deviation 6.24
No ContactApathy Evaluation Scale--PWD22.87 score on a scaleStandard Deviation 7.5
Secondary

Community Structure--PWD

This is a brain imaging variable derived from fMRI images. Modularity (Q) ranges from 0 (no community structure) to 1 (perfectly modular network). One Q-value is generated for each person and group averages are shown.

Time frame: Week 12

Population: Numbers at baseline and week 12 differ due to withdrawals, poor data quality, and inability to complete scans.

ArmMeasureValue (MEAN)Dispersion
Dance GroupCommunity Structure--PWD.74 Q-ValueStandard Deviation 0.04
Non-group DanceCommunity Structure--PWD.73 Q-ValueStandard Deviation 0.05
Social GroupCommunity Structure--PWD.75 Q-ValueStandard Deviation 0.04
No ContactCommunity Structure--PWD.75 Q-ValueStandard Deviation 0.03
Secondary

Community Structure--PWD

This is a brain imaging variable derived from fMRI images. Modularity (Q) ranges from 0 (no community structure) to 1 (perfectly modular network). One Q-value is generated for each person and group averages are shown.

Time frame: Baseline

Population: Participants are missing at baseline imaging data due to an undisclosed contraindicated device, aborting scan, refusing scans, or excessive head motion.

ArmMeasureValue (MEAN)Dispersion
Dance GroupCommunity Structure--PWD.74 Q-ValueStandard Deviation 0.05
Non-group DanceCommunity Structure--PWD.72 Q-ValueStandard Deviation 0.05
Social GroupCommunity Structure--PWD.73 Q-ValueStandard Deviation 0.05
No ContactCommunity Structure--PWD.74 Q-ValueStandard Deviation 0.04
Secondary

Expanded Short Physical Performance Battery (eSPPB)

The eSPPB is a brief test of global mobility function with excellent test-retest and inter-examiner reliability; is sensitive to change; is safe, and is a robust predictor of future physical disability and death. To avoid ceiling effects, investigators will use an expanded version (eSPPB) that increases the difficulty of the standing balance task by asking participants to hold postures for 30 instead of 10 seconds, adds a one-leg stand, and adds a narrow walk. The resulting score is normally distributed, continuous, and shows greater sensitivity to change. Dementia patients have lower scores on the SPPB so a favorable outcome for this outcome measure would be a significantly higher score post treatment. The eSPPB is scored as a continuous measure with a minimum score of 0 and a maximum score of 3.0 where 3 is the best possible outcome.

Time frame: Week 12

Population: Number at baseline and follow-up differ due to withdrawals, staff error, participant unwilling to complete, and participant unable to complete test.

ArmMeasureValue (MEAN)Dispersion
Dance GroupExpanded Short Physical Performance Battery (eSPPB)1.62 score on a scaleStandard Deviation 0.57
Non-group DanceExpanded Short Physical Performance Battery (eSPPB)1.98 score on a scaleStandard Deviation 0.39
Social GroupExpanded Short Physical Performance Battery (eSPPB)1.66 score on a scaleStandard Deviation 0.44
No ContactExpanded Short Physical Performance Battery (eSPPB)1.88 score on a scaleStandard Deviation 0.5
Secondary

Expanded Short Physical Performance Battery (eSPPB)

The eSPPB is a brief test of global mobility function with excellent test-retest and inter-examiner reliability; is sensitive to change; is safe, and is a robust predictor of future physical disability and death. To avoid ceiling effects, investigators will use an expanded version (eSPPB) that increases the difficulty of the standing balance task by asking participants to hold postures for 30 instead of 10 seconds, adds a one-leg stand, and adds a narrow walk. The resulting score is normally distributed, continuous, and shows greater sensitivity to change. Dementia patients have lower scores on the SPPB so a favorable outcome for this outcome measure would be a significantly higher score post treatment. The eSPPB is scored as a continuous measure with a minimum score of 0 and a maximum score of 3.0 where 3 is the best possible outcome.

Time frame: Baseline

ArmMeasureValue (MEAN)Dispersion
Dance GroupExpanded Short Physical Performance Battery (eSPPB)1.57 score on a scaleStandard Deviation 0.55
Non-group DanceExpanded Short Physical Performance Battery (eSPPB)1.99 score on a scaleStandard Deviation 0.37
Social GroupExpanded Short Physical Performance Battery (eSPPB)1.67 score on a scaleStandard Deviation 0.46
No ContactExpanded Short Physical Performance Battery (eSPPB)1.86 score on a scaleStandard Deviation 0.4
Secondary

Falls Efficacy Scale - International (FES) PWD

A 16-item scale to assess fear of falling where higher scores reflect a higher fear and risk of falling. Out of a total score of 100, a score of 70 or above indicates the individual has a fear of falling.

Time frame: Baseline

ArmMeasureValue (MEAN)Dispersion
Dance GroupFalls Efficacy Scale - International (FES) PWD27.54 score on a scaleStandard Deviation 10.06
Non-group DanceFalls Efficacy Scale - International (FES) PWD22.64 score on a scaleStandard Deviation 4.86
Social GroupFalls Efficacy Scale - International (FES) PWD26.07 score on a scaleStandard Deviation 7.76
No ContactFalls Efficacy Scale - International (FES) PWD25.56 score on a scaleStandard Deviation 8.65
Secondary

Falls Efficacy Scale - International (FES) PWD

A 16-item scale to assess fear of falling where higher scores reflect a higher fear and risk of falling. Out of a total score of 100, a score of 70 or above indicates the individual has a fear of falling.

Time frame: Week 12

Population: Overall number of participants analyzed corresponds to the number of participants who completed the study.

ArmMeasureValue (MEAN)Dispersion
Dance GroupFalls Efficacy Scale - International (FES) PWD27.23 score on a scaleStandard Deviation 10.38
Non-group DanceFalls Efficacy Scale - International (FES) PWD21.73 score on a scaleStandard Deviation 5.32
Social GroupFalls Efficacy Scale - International (FES) PWD25.36 score on a scaleStandard Deviation 5.27
No ContactFalls Efficacy Scale - International (FES) PWD28.09 score on a scaleStandard Deviation 11.42
Secondary

Fullerton Advanced Balance Scale (Overall Balance) PWD

Fullerton Advanced Balance Scale (FAB) measures balance using 10 different performance-based tests (scored 0 worst - 4 best), including; standing with feet together and eyes closed, standing on a foam pad with eyes closed, walking while turning the head from side to side rhythmically, functional standing reach, turning around to the left and right, stepping up and over a 6-inch box, standing on one leg, and a test for postural reaction. The scale goes from 0-40 with 40 being the best outcome and a cutoff of \<=25 for risk of falls.

Time frame: Baseline

Population: One participant is missing baseline data due to a recording error during data collection.

ArmMeasureValue (MEAN)Dispersion
Dance GroupFullerton Advanced Balance Scale (Overall Balance) PWD23.71 score on a scaleStandard Deviation 8.22
Non-group DanceFullerton Advanced Balance Scale (Overall Balance) PWD27.88 score on a scaleStandard Deviation 5.4
Social GroupFullerton Advanced Balance Scale (Overall Balance) PWD24.22 score on a scaleStandard Deviation 6.32
No ContactFullerton Advanced Balance Scale (Overall Balance) PWD26.79 score on a scaleStandard Deviation 4.57
Secondary

Fullerton Advanced Balance Scale (Overall Balance) PWD

Fullerton Advanced Balance Scale (FAB) measures balance using 10 different performance-based tests (scored 0 worst - 4 best), including; standing with feet together and eyes closed, standing on a foam pad with eyes closed, walking while turning the head from side to side rhythmically, functional standing reach, turning around to the left and right, stepping up and over a 6-inch box, standing on one leg, and a test for postural reaction. The scale goes from 0-40 with 40 being the best outcome and a cutoff of \<=25 for risk of falls.

Time frame: Week 12

Population: Number at baseline and week 12 differ due to withdrawals.

ArmMeasureValue (MEAN)Dispersion
Dance GroupFullerton Advanced Balance Scale (Overall Balance) PWD23.41 score on a scaleStandard Deviation 8.57
Non-group DanceFullerton Advanced Balance Scale (Overall Balance) PWD29.95 score on a scaleStandard Deviation 4.33
Social GroupFullerton Advanced Balance Scale (Overall Balance) PWD24.27 score on a scaleStandard Deviation 6.26
No ContactFullerton Advanced Balance Scale (Overall Balance) PWD26.78 score on a scaleStandard Deviation 6.65
Secondary

Gait Speed--PWD

The time one takes to walk a specified distance on level surfaces over a short distance. 4m usual gait speed was measured as part of the eSPPB.

Time frame: Baseline

ArmMeasureValue (MEAN)Dispersion
Dance GroupGait Speed--PWD5.47 secondsStandard Deviation 1.55
Non-group DanceGait Speed--PWD4.61 secondsStandard Deviation 1.03
Social GroupGait Speed--PWD5.12 secondsStandard Deviation 1.39
No ContactGait Speed--PWD4.66 secondsStandard Deviation 0.85
Secondary

Gait Speed--PWD

The time one takes to walk a specified distance on level surfaces over a short distance. 4m usual gait speed was measured as part of the eSPPB.

Time frame: Week 12

Population: Number at baseline and follow-up differ due to withdrawals, staff error, participant unwilling to complete and participant unable to complete.

ArmMeasureValue (MEAN)Dispersion
Dance GroupGait Speed--PWD5.51 secondsStandard Deviation 1.71
Non-group DanceGait Speed--PWD4.79 secondsStandard Deviation 0.94
Social GroupGait Speed--PWD5.12 secondsStandard Deviation 1.06
No ContactGait Speed--PWD4.77 secondsStandard Deviation 1.14
Secondary

Gait Variability--PWD

Stride time variability, which is calculated out of the mean and standard deviation of stride time, reflects the change in time elapsed between the first two contacts of two consecutive footfalls of the same foot over a number of gait cycles. Increased gait variability is associated with increased fall risk in older adults.

Time frame: Week 12

Population: Subject numbers differ due to equipment failure, technical error, subjects withdrawing, subject inability to complete task, or subject unwilling to complete task.

ArmMeasureValue (MEAN)Dispersion
Dance GroupGait Variability--PWD4.46 percentage of variabilityStandard Deviation 2.88
Non-group DanceGait Variability--PWD2.71 percentage of variabilityStandard Deviation 0.75
Social GroupGait Variability--PWD3.45 percentage of variabilityStandard Deviation 1.3
No ContactGait Variability--PWD4.06 percentage of variabilityStandard Deviation 4.15
Secondary

Gait Variability--PWD

Stride time variability, which is calculated out of the mean and standard deviation of stride time, reflects the change in time elapsed between the first two contacts of two consecutive footfalls of the same foot over a number of gait cycles. Increased gait variability is associated with increased fall risk in older adults.

Time frame: Baseline

Population: Subject numbers differ due to equipment failure, subjects withdrawing, subject inability to complete task, or lost to follow up.

ArmMeasureValue (MEAN)Dispersion
Dance GroupGait Variability--PWD3.41 percentage of variabilityStandard Deviation 1.57
Non-group DanceGait Variability--PWD3.10 percentage of variabilityStandard Deviation 1.68
Social GroupGait Variability--PWD3.44 percentage of variabilityStandard Deviation 1.27
No ContactGait Variability--PWD3.15 percentage of variabilityStandard Deviation 1.07
Secondary

Geriatric Anxiety Scale

The Geriatric Anxiety Scale measures symptoms of anxiety in older adults. A single total score ranges from 0 (low anxiety) to 63 (high anxiety). Four cutoff scores have been provided by authors in the manuals: 0-7 (normal anxiety), 8-15 (mild-moderate anxiety), 16-25 (moderate-severe anxiety), and 26-63 (severe anxiety).

Time frame: Baseline

Population: Results at baseline for this outcome represent all PWD who were randomized.

ArmMeasureValue (MEAN)Dispersion
Dance GroupGeriatric Anxiety Scale3.71 score on a scaleStandard Deviation 3.34
Non-group DanceGeriatric Anxiety Scale2.92 score on a scaleStandard Deviation 2.06
Social GroupGeriatric Anxiety Scale4.04 score on a scaleStandard Deviation 3.01
No ContactGeriatric Anxiety Scale3.56 score on a scaleStandard Deviation 3.31
Secondary

Geriatric Anxiety Scale

The Geriatric Anxiety Scale measures symptoms of anxiety in older adults. A single total score ranges from 0 (low anxiety) to 63 (high anxiety). Four cutoff scores have been provided by authors in the manuals: 0-7 (normal anxiety), 8-15 (mild-moderate anxiety), 16-25 (moderate-severe anxiety), and 26-63 (severe anxiety).

Time frame: Week 12

Population: Overall number of participants analyzed corresponds to the number of participants who completed the study.

ArmMeasureValue (MEAN)Dispersion
Dance GroupGeriatric Anxiety Scale3.64 score on a scaleStandard Deviation 3.63
Non-group DanceGeriatric Anxiety Scale2.23 score on a scaleStandard Deviation 1.57
Social GroupGeriatric Anxiety Scale3.64 score on a scaleStandard Deviation 3.27
No ContactGeriatric Anxiety Scale4.0 score on a scaleStandard Deviation 4.65
Secondary

Geriatric Depression Scale

The person with dementia will be asked to complete a screening tool for assessing depression. This test has 15 yes/no questions with a yes receiving 1 point for a depressive answer. A total score is calculated and will be on a scale from 0-15 with 0-4 indicating no depression, 5-10 suggestive of a mild depression, and 11+ suggestive of severe depression.

Time frame: Baseline

Population: Results at baseline for this outcome represent all PWD who were randomized.

ArmMeasureValue (MEAN)Dispersion
Dance GroupGeriatric Depression Scale2.17 score on a scaleStandard Deviation 2.5
Non-group DanceGeriatric Depression Scale1.24 score on a scaleStandard Deviation 1.05
Social GroupGeriatric Depression Scale2.37 score on a scaleStandard Deviation 2.13
No ContactGeriatric Depression Scale2.04 score on a scaleStandard Deviation 2.28
Secondary

Geriatric Depression Scale

The person with dementia will be asked to complete a screening tool for assessing depression. This test has 15 yes/no questions with a yes receiving 1 point for a depressive answer. A total score is calculated and will be on a scale from 0-15 with 0-4 indicating no depression, 5-10 suggestive of a mild depression, and 11+ suggestive of severe depression.

Time frame: Week 12

Population: Overall number of participants analyzed corresponds to the number of participants who completed the study.

ArmMeasureValue (MEAN)Dispersion
Dance GroupGeriatric Depression Scale2.27 score on a scaleStandard Deviation 2.76
Non-group DanceGeriatric Depression Scale1.32 score on a scaleStandard Deviation 1.36
Social GroupGeriatric Depression Scale1.68 score on a scaleStandard Deviation 1.29
No ContactGeriatric Depression Scale2.74 score on a scaleStandard Deviation 3.54
Secondary

Global Efficiency (eGlob)--PWD

This is a brain imaging variable derived from fMRI images.Scale ranges from 0 (no long-range information processing) to 1 (maximal distributed processing). Decreased Eglob has been associated with aging, cognitive impairment, and depression.

Time frame: Baseline

Population: Participants are missing at baseline imaging data due to an undisclosed contraindicated device, aborting scan, refusing scans, or excessive head motion.

ArmMeasureValue (MEAN)Dispersion
Dance GroupGlobal Efficiency (eGlob)--PWD.19 score on a scaleStandard Deviation 0.02
Non-group DanceGlobal Efficiency (eGlob)--PWD.18 score on a scaleStandard Deviation 0.03
Social GroupGlobal Efficiency (eGlob)--PWD.19 score on a scaleStandard Deviation 0.03
No ContactGlobal Efficiency (eGlob)--PWD.19 score on a scaleStandard Deviation 0.03
Secondary

Global Efficiency (eGlob)--PWD

This is a brain imaging variable derived from fMRI images.Scale ranges from 0 (no long-range information processing) to 1 (maximal distributed processing). Decreased Eglob has been associated with aging, cognitive impairment, and depression.

Time frame: Week 12

Population: Number at baseline and follow-up differ due to withdrawals, poor data quality, participant refusal of procedure, inability to complete scan.

ArmMeasureValue (MEAN)Dispersion
Dance GroupGlobal Efficiency (eGlob)--PWD.19 score on a scaleStandard Deviation 0.03
Non-group DanceGlobal Efficiency (eGlob)--PWD.18 score on a scaleStandard Deviation 0.03
Social GroupGlobal Efficiency (eGlob)--PWD.19 score on a scaleStandard Deviation 0.02
No ContactGlobal Efficiency (eGlob)--PWD.19 score on a scaleStandard Deviation 0.03
Secondary

Local Efficiency (eLoc)--PWD

Scale ranges from 0 (no local connectivity) to 1 (maximal local connectivity - all connections are local) and has been observed to change with cognitive impairment and depression.

Time frame: Week 12

Population: Number at baseline and follow-up differ due to withdrawals, poor data quality, participant refusal of procedure, inability to complete scan.

ArmMeasureValue (MEAN)Dispersion
Dance GroupLocal Efficiency (eLoc)--PWD.58 units on a scaleStandard Deviation 0.03
Non-group DanceLocal Efficiency (eLoc)--PWD.58 units on a scaleStandard Deviation 0.03
Social GroupLocal Efficiency (eLoc)--PWD.59 units on a scaleStandard Deviation 0.03
No ContactLocal Efficiency (eLoc)--PWD.58 units on a scaleStandard Deviation 0.04
Secondary

Local Efficiency (eLoc)--PWD

Scale ranges from 0 (no local connectivity) to 1 (maximal local connectivity - all connections are local) and has been observed to change with cognitive impairment and depression.

Time frame: Baseline

Population: Participants are missing at baseline imaging data due to an undisclosed contraindicated device, aborting scan, refusing scans, or excessive head motion.

ArmMeasureValue (MEAN)Dispersion
Dance GroupLocal Efficiency (eLoc)--PWD.59 units on a scaleStandard Deviation 0.03
Non-group DanceLocal Efficiency (eLoc)--PWD.57 units on a scaleStandard Deviation 0.04
Social GroupLocal Efficiency (eLoc)--PWD.59 units on a scaleStandard Deviation 0.03
No ContactLocal Efficiency (eLoc)--PWD.58 units on a scaleStandard Deviation 0.04
Secondary

Neuropsychiatric Inventory Questionnaire (NPI-Q)

The NPI is a reliable and valid structured interview designed to assess neuropsychiatric symptoms in person with dementia through a structured interview with the caregiver. The NPI includes questions about 12 domains of symptoms: delusions, hallucinations, agitation/aggression, depression, anxiety, elation/ euphoria, apathy, disinhibition, irritability, aberrant motor activity, sleep, and eating. For each, symptom severity is scored on a scale of 0-4, with 4 being the worst outcome and caregiver distress is scored on a scale from 0-5, with 5 being the worst outcome. The sum of all 12 domains is calculated. Severity scores are reported here with a range from 0-36 with a higher score reflecting greater symptom severity.

Time frame: Baseline

ArmMeasureValue (MEAN)Dispersion
Dance GroupNeuropsychiatric Inventory Questionnaire (NPI-Q)6.83 score on a scaleStandard Deviation 5.64
Non-group DanceNeuropsychiatric Inventory Questionnaire (NPI-Q)5.44 score on a scaleStandard Deviation 4.44
Social GroupNeuropsychiatric Inventory Questionnaire (NPI-Q)6.85 score on a scaleStandard Deviation 4.86
No ContactNeuropsychiatric Inventory Questionnaire (NPI-Q)7.72 score on a scaleStandard Deviation 6.13
Secondary

NPI-Q

The NPI is a reliable and valid structured interview designed to assess neuropsychiatric symptoms in person with dementia through a structured interview with the caregiver. The NPI includes questions about 12 domains of symptoms: delusions, hallucinations, agitation/aggression, depression, anxiety, elation/ euphoria, apathy, disinhibition, irritability, aberrant motor activity, sleep, and eating. For each, symptom severity is scored on a scale of 0-4, with 4 being the worst outcome and caregiver distress is scored on a scale from 0-5, with 5 being the worst outcome. The sum of all 12 domains is calculated. Severity scores are reported here with a range from 0-36 with a higher score reflecting greater symptom severity.

Time frame: Week 12

Population: Number at baseline and follow-up differ due to withdrawals and due to staff error during data collection.

ArmMeasureValue (MEAN)Dispersion
Dance GroupNPI-Q6.38 score on a scaleStandard Deviation 5.48
Non-group DanceNPI-Q5.22 score on a scaleStandard Deviation 4.66
Social GroupNPI-Q5.63 score on a scaleStandard Deviation 5.71
No ContactNPI-Q8.39 score on a scaleStandard Deviation 5.25
Secondary

Path Length--PWD

Refers to the number of edges that must be crossed to get from one node to another. Longer path length in people with AD has been associated with slower cognitive performance, beta amyloid deposition, and depression.

Time frame: Baseline

Population: Participants are missing at baseline imaging data due to an undisclosed contraindicated device, aborting scan, refusing scans, or excessive head motion.

ArmMeasureValue (MEAN)Dispersion
Dance GroupPath Length--PWD5.29 Number of EdgesStandard Deviation 0.58
Non-group DancePath Length--PWD5.69 Number of EdgesStandard Deviation 1.17
Social GroupPath Length--PWD5.42 Number of EdgesStandard Deviation 0.78
No ContactPath Length--PWD5.52 Number of EdgesStandard Deviation 0.93
Secondary

Path Length--PWD

Refers to the number of edges that must be crossed to get from one node to another. Longer path length in people with AD has been associated with slower cognitive performance, beta amyloid deposition, and depression.

Time frame: Week 12

Population: Number at baseline and follow-up differ due to withdrawals, poor data quality, participant refusal of procedure, inability to complete scan.

ArmMeasureValue (MEAN)Dispersion
Dance GroupPath Length--PWD5.30 Number of EdgesStandard Deviation 0.93
Non-group DancePath Length--PWD5.61 Number of EdgesStandard Deviation 0.8
Social GroupPath Length--PWD5.36 Number of EdgesStandard Deviation 0.54
No ContactPath Length--PWD5.54 Number of EdgesStandard Deviation 1.09
Secondary

Postural Sway--PWD

Center of pressure displacement (area of the 95% confidence ellipse) using an AccuSway forceplate. Center of pressure displacement is one way to characterize postural sway. Increased postural sway is correlated with decreased balance in older adults and increased fall risk. Center of pressure displacement was measured using the area of the 95% confidence ellipse using an AccuSway forceplate. Higher numbers indicate greater levels of postural sway.

Time frame: Week 12

Population: Numbers averaged at baseline and follow-up differ due to withdrawals, technical errors, safety concern, participant unwilling and participant unable to continue.

ArmMeasureValue (MEAN)Dispersion
Dance GroupPostural Sway--PWD0.41 centimeter squaredStandard Deviation 0.22
Non-group DancePostural Sway--PWD0.38 centimeter squaredStandard Deviation 0.2
Social GroupPostural Sway--PWD0.41 centimeter squaredStandard Deviation 0.26
No ContactPostural Sway--PWD0.52 centimeter squaredStandard Deviation 0.42
Secondary

Postural Sway--PWD

Center of pressure displacement (area of the 95% confidence ellipse) using an AccuSway forceplate. Center of pressure displacement is one way to characterize postural sway. Increased postural sway is correlated with decreased balance in older adults and increased fall risk. Center of pressure displacement was measured using the area of the 95% confidence ellipse using an AccuSway forceplate. Higher numbers indicate greater levels of postural sway.

Time frame: Baseline

Population: Number of participants analyzed at baseline differs due to technical error.

ArmMeasureValue (MEAN)Dispersion
Dance GroupPostural Sway--PWD0.42 centimeter squaredStandard Deviation 0.37
Non-group DancePostural Sway--PWD0.37 centimeter squaredStandard Deviation 0.14
Social GroupPostural Sway--PWD0.36 centimeter squaredStandard Deviation 0.21
No ContactPostural Sway--PWD0.49 centimeter squaredStandard Deviation 0.44
Other Pre-specified

Blood-based Stress Biomarkers (Covariate or Alternative Hypothesis)

Social engagement may change biomarkers of stress relevant for interpreting outcomes. These stress biomarkers include cortisol and allostatic load, a composite measure of blood-based biomarkers associated with chronically elevated stress. PWD only

Time frame: Baseline, Week 12

Other Pre-specified

Blood Pressure

PWD only

Time frame: Baseline, Week12

Other Pre-specified

Body Mass Index (BMI)

a measure of body fat based on height and weight that applies to adult men and women--PWD only

Time frame: Baseline, Week 12

Other Pre-specified

Caregiver Burden With Zarit Caregiver Burden Scale--Covariate or Alternative Hypothesis

The Zarit Caregiver Burden Scale is administered in interview form to the caregiver. It consists of 22 questions scored 0-4 with 0=Never, 1=Rarely, 2=Sometimes, 3=Quite Frequently, 4=Nearly Always. The total score range is 0-88 with 88 being the worst possible outcome. 0-20 represents little or no burden on the caregiver, 21-40 represents mild to moderate burden, 41-60 represents moderate to severe burden, and 61-88 represents severe burden.

Time frame: Baseline, Week 12

Other Pre-specified

Caregiver Quality of Life With the 36-item Short-Form Health (SF-36)--Covariate or Alternative Hypothesis

The SF-36 consists of 36 questions assessing physical functioning, role functioning difficulties caused by physical problems, bodily pain, general health, vitality, social functioning, role functioning difficulties caused by emotional problems, and mental health. High scores are representative of a great health status and better outcomes, while low scores are representative of a poor health status.

Time frame: Baseline, Week 12

Other Pre-specified

Neuroticism-Extraversion-Openness Five-Factor Inventory (NEO-FFI)

A measure of five domains of personality (neuroticism, extraversion, openness, agreeableness, and conscientiousness). A higher score on any scale indicates stronger presence of that trait. PWD only

Time frame: Baseline

Other Pre-specified

White Matter Lesion Burden

The volume of white matter lesions is calculated using the Lesion Segmentation Toolbox. PWD only.

Time frame: Baseline, Week 12

Source: ClinicalTrials.gov · Data processed: Feb 13, 2026